As a proof-of-concept project, this study demonstrated that the saRNA approach is a potent method to enhance the expression of tumor metastasis suppressor DPYSL3 gene, which depends on the sequence specificity of the target gene promoter. Here, DPYSL3 is linked to neoplasm.